ARCHIVES

FDA, NCI, CMS Announce Biomarker Initiative; First Project To Validate FDG-PET As Predictor Of Tumor Response In Non-Hodgkin’s Lymphoma.

This article is from The Cancer Letter archive.

Vol. 32 No. 06 | February 17, 2006

Download PDF Visit The Full Archive

Related Articles

NCI Staff Will Recommend That Comprehensive Recognition Be Withdrawn From Colorado Center

October 31, 1980

Loss Of Core Grants Imperials Status Of Three Comprehensive Cancer Centers

July 14, 1989

Letter: Biostatistics Directors Invited To Share Concerns

June 7, 1996

New Regimens May Benefit Multiple Myeloma Patients

January 28, 2005

Four Patients In Tamoxifin Treatment Trial Had Died of Uterine Cancer Prior To BCPT

April 29, 1994

Protection Commission Asks Hew To Adopt Entire Report As Policy for Human Subject Research

April 27, 1979